Staphylococcus pettenkoferi

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Staphylococcus pettenkoferi is a Gram-positive, non-spore-forming, facultatively anaerobic, non-motile, coccus bacterium. It has been detected in at least 3 gut microbiome compilation studies or metastudies. Staphylococcus pettenkoferi is probably a rare gut coloniser. (Truelzsch2002; Truelzsch2007)



  • This organism has been recovered from clinical sources (blood) and human faeces. The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread. Could be a possible pathogen in humans, but unknown at this stage. Is a known gut commensal.
    • GENERAL CHARACTERISTICS (Truelzsch2002); (Truelzsch2007);
    Character Response
  • Substrates hydrolysed or digested:
  • urea;
  • H+
  • Acid from carbohydrates usually produced:
  • fructose;
  • ±
  • Strain-dependent acid from carbs:
  • glucose; sucrose;
  • ⥅
  • Substrates assimilated or utilised:
  • fructose; glucose; sucrose;
  • ±
  • Strain-dependent substrate utilisation:
  • trehalose;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; catalase; esterase C4; esterase lipase C8; pyrrolidine arylamidase; urease;
    • SPECIAL FEATURES (Truelzsch2002); (Truelzsch2007);
    Character Response
  • ✗
  • VP test:
  • not active
  • ✓
  • Nitrate:
  • reduced
  • Pigments:
  • variable
    • RESPONSE TO ANTIBIOTICS (Truelzsch2002); (Truelzsch2007);
    Class Active Resistant
  • Penicillins:
  • oxacillin; penicillin G;
  • Cephalosporins:
  • cefuroxime;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • Quinolines:
  • ciprofloxacin; moxifloxacin;
  • Aminoglycosides:
  • amikacin; gentamicin; netilmycin; tobramycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • fusidic-acid;
  • fosfomycin;
  • Vancomycins:
  • vancomycin;
  • Miscellaneous antibiotics:
  • linezolid; novobiocin;
  • polymyxin B;

  • Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Bacillales Family:  Staphylococcaceae Genus:  Staphylococcus Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Sessile Morphology:  Coccus Pigment:  variable
    Health:  Unknown
    Source:  clinical sources (blood) and human faeces
    		Aesculin:  neg Urea:  + Gelatin:  neg DNA:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg Fructose:  + Glucose:  d Ribose:  neg Xylose:  neg Cellubiose:  neg Lactose:  neg Maltose:  neg Sucrose:  d Trehalose:  neg Turanose:  neg Glycogen:  neg Mannitol:  neg Xylitol:  neg Me-α-D-Glc:  vr NAc-α-GA:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  neg Fructose:  + Galactose:  neg Glucose:  + Mannose:  neg Ribose:  neg Xylose:  neg Cellubiose:  neg Lactose:  neg Maltose:  neg Melezitose:  neg Raffinose:  neg Sucrose:  + D-Turanose:  neg Trehalose:  d Mannitol:  neg Salicin:  neg Xylitol:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  + Urease:  + Coagulase:  neg Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg α-Mannosidase:  neg ArgDH:  neg OrnDC:  neg ArgAA:  neg LeuAA:  neg PyrrolidAA:  + AlkalineP:  + AcidP:  + DNAse:  neg Esterase(C4):  + EstLip(C8):  + Lipase(C14):  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Pigment:  variable
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    oxacillin:  S(vr)
    penicillin_G:  S(vr)
    cefuroxime:  Sens
    amikacin:  Sens
    gentamicin:  Sens
    netilmycin:  Sens
    tobramycin:  Sens
    erythromycin:  S(vr)
    linezolid:  Sens
    ciprofloxacin:  S(vr)
    moxifloxacin:  S(vr)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  Sens
    vancomycin:  Sens
    rifampicin:  Sens
    fosfomycin:  Res
    SXT:  Var
    clindamycin:  Var
    novobiocin:  Sens
    polymyxin_B:  Res
    fusidic-acid:  Sens

    References

    SPECIFIC REFERENCES FOR STAPHYLOCOCCUS PETTENKOFERI
  • Truelzsch2002 - Staphylococcus pettenkoferi', a novel staphylococcal species isolated from clinical specimens.
  • Truelzsch2007 - Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR STAPHYLOCOCCUS PETTENKOFERI
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • ...............................
    • GENERAL REFERENCES FOR STAPHYLOCOCCUS PETTENKOFERI
  • Ludwig2009 - Revised road map to the phylum Firmicutes.
    • Added: April 08, 2021